Publication Information

{'id': 'https://openalex.org/W1925251699', 'doi': 'https://doi.org/10.1111/j.1365-4632.2010.04708.x', 'title': 'Cetirizine hydrochloride suppresses the CCL17 production of epidermal keratinocytes and dermal fibroblasts', 'display_name': 'Cetirizine hydrochloride suppresses the CCL17 production of epidermal keratinocytes and dermal fibroblasts', 'publication_year': 2012, 'publication_date': '2012-07-12', 'ids': {'openalex': 'https://openalex.org/W1925251699', 'doi': 'https://doi.org/10.1111/j.1365-4632.2010.04708.x', 'mag': '1925251699', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/22788822'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1111/j.1365-4632.2010.04708.x', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-4632.2010.04708.x', 'source': {'id': 'https://openalex.org/S32635664', 'display_name': 'International Journal of Dermatology', 'issn_l': '0011-9059', 'issn': ['0011-9059', '1365-4362', '1365-4632'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'letter', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-4632.2010.04708.x', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5044253913', 'display_name': 'Yuichiro Tsunemi', 'orcid': 'https://orcid.org/0000-0003-3590-6489'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Yuichiro Tsunemi', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5024531277', 'display_name': 'Hidehisa Saeki', 'orcid': 'https://orcid.org/0000-0002-1095-0355'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Hidehisa Saeki', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110358897', 'display_name': 'Kunihiko Tamaki', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Kunihiko Tamaki', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101780839', 'display_name': 'Shinichi Sato', 'orcid': 'https://orcid.org/0000-0001-5519-172X'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Shinichi Sato', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5018150140', 'display_name': 'Koichiro Nakamura', 'orcid': 'https://orcid.org/0000-0002-0367-0312'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Koichiro Nakamura', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 3760, 'currency': 'USD', 'value_usd': 3760, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': None, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 3, 'citation_normalized_percentile': {'value': 0.403537, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 75, 'max': 78}, 'biblio': {'volume': '51', 'issue': '8', 'first_page': '1003', 'last_page': '1005'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10837', 'display_name': 'Dermatology and Skin Diseases', 'score': 0.9984, 'subfield': {'id': 'https://openalex.org/subfields/2708', 'display_name': 'Dermatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10837', 'display_name': 'Dermatology and Skin Diseases', 'score': 0.9984, 'subfield': {'id': 'https://openalex.org/subfields/2708', 'display_name': 'Dermatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10031', 'display_name': 'T-cell and B-cell Immunology', 'score': 0.9955, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11591', 'display_name': 'NF-κB Signaling Pathways', 'score': 0.9938, 'subfield': {'id': 'https://openalex.org/subfields/1306', 'display_name': 'Cancer Research'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.48199052}], 'mesh': [{'descriptor_ui': 'D017332', 'descriptor_name': 'Cetirizine', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D054414', 'descriptor_name': 'Chemokine CCL17', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': True}, {'descriptor_ui': 'D004817', 'descriptor_name': 'Epidermis', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D005347', 'descriptor_name': 'Fibroblasts', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D039563', 'descriptor_name': 'Histamine H1 Antagonists, Non-Sedating', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D015603', 'descriptor_name': 'Keratinocytes', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D002460', 'descriptor_name': 'Cell Line', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017332', 'descriptor_name': 'Cetirizine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D054414', 'descriptor_name': 'Chemokine CCL17', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D054414', 'descriptor_name': 'Chemokine CCL17', 'qualifier_ui': 'Q000096', 'qualifier_name': 'biosynthesis', 'is_major_topic': False}, {'descriptor_ui': 'D004817', 'descriptor_name': 'Epidermis', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D004817', 'descriptor_name': 'Epidermis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005347', 'descriptor_name': 'Fibroblasts', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D005347', 'descriptor_name': 'Fibroblasts', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D039563', 'descriptor_name': 'Histamine H1 Antagonists, Non-Sedating', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015603', 'descriptor_name': 'Keratinocytes', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D015603', 'descriptor_name': 'Keratinocytes', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1111/j.1365-4632.2010.04708.x', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-4632.2010.04708.x', 'source': {'id': 'https://openalex.org/S32635664', 'display_name': 'International Journal of Dermatology', 'issn_l': '0011-9059', 'issn': ['0011-9059', '1365-4362', '1365-4632'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/22788822', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1111/j.1365-4632.2010.04708.x', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-4632.2010.04708.x', 'source': {'id': 'https://openalex.org/S32635664', 'display_name': 'International Journal of Dermatology', 'issn_l': '0011-9059', 'issn': ['0011-9059', '1365-4362', '1365-4632'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 10, 'referenced_works': ['https://openalex.org/W1964354952', 'https://openalex.org/W1969063232', 'https://openalex.org/W2011956444', 'https://openalex.org/W2028182447', 'https://openalex.org/W2044368255', 'https://openalex.org/W2072462906', 'https://openalex.org/W2080490309', 'https://openalex.org/W2100045991', 'https://openalex.org/W2130882441', 'https://openalex.org/W2338141054'], 'related_works': ['https://openalex.org/W4389568370', 'https://openalex.org/W3108674512', 'https://openalex.org/W3032375762', 'https://openalex.org/W3031052312', 'https://openalex.org/W2748952813', 'https://openalex.org/W2586801360', 'https://openalex.org/W2080531066', 'https://openalex.org/W1995515455', 'https://openalex.org/W1506200166', 'https://openalex.org/W1489783725'], 'abstract_inverted_index': {'International': [0], 'Journal': [1], 'of': [2, 16, 162, 188, 198, 211, 222, 245, 284, 310, 355, 390, 418, 451, 487, 492, 500, 519], 'DermatologyVolume': [3], '51,': [4], 'Issue': [5], '8': [6, 442], 'p.': [7], '1003-1005': [8, 538], 'Correspondence': [9], 'Cetirizine': [10], 'hydrochloride': [11, 453], 'suppresses': [12, 307], 'the': [13, 166, 204, 214, 282, 308], 'CCL17': [14], 'production': [15, 396, 428, 459], 'epidermal': [17], 'keratinocytes': [18], 'and': [19, 186, 190, 202, 209, 228, 331, 335, 357, 361, 371, 392, 397, 426, 456, 489, 498, 524], 'dermal': [20], 'fibroblasts': [21, 367], 'Yuichiro': [22, 26, 88, 92], 'Tsunemi': [23, 27, 89, 93], 'MD,': [24, 28, 37, 41, 50, 54, 63, 67, 76, 80, 90, 94, 103, 107, 116, 120, 129, 133, 142, 146], 'PhD,': [25, 38, 51, 64, 77, 91, 104, 117, 130, 143], 'PhDSearch': [29, 42, 55, 68, 81, 95, 108, 121, 134, 147], 'for': [30, 43, 56, 69, 82, 96, 109, 122, 135, 148], 'more': [31, 44, 57, 70, 83, 97, 110, 123, 136, 149], 'papers': [32, 45, 58, 71, 84, 98, 111, 124, 137, 150], 'by': [33, 46, 59, 72, 85, 99, 112, 125, 138, 151, 365, 400, 429], 'this': [34, 47, 60, 73, 86, 100, 113, 126, 139, 152, 223], 'authorHidehisa': [35, 101], 'Saeki': [36, 40, 102, 106, 326], 'Hidehisa': [39, 105], 'authorKunihiko': [48, 114], 'Tamaki': [49, 53, 115, 119, 328], 'Kunihiko': [52, 118], 'authorShinichi': [61, 127], 'Sato': [62, 66, 128, 132], 'Shinichi': [65, 131], 'authorKoichiro': [74, 140], 'Nakamura': [75, 79, 141, 145, 413], 'Koichiro': [78, 144], 'author': [87, 153], 'First': [154], 'published:': [155], '12': [156], 'July': [157], '2012': [158], 'https://doi.org/10.1111/j.1365-4632.2010.04708.xCitations:': [159], '3': [160, 294], 'Conflicts': [161], 'interest:': [163], 'None.': [164], 'Read': [165], 'full': [167, 178], 'textAboutPDF': [168], 'ToolsRequest': [169], 'permissionExport': [170], 'citationAdd': [171], 'to': [172, 194, 217, 467], 'favoritesTrack': [173], 'citation': [174], 'ShareShare': [175], 'Give': [176], 'accessShare': [177, 180], 'text': [179], 'full-text': [181, 196, 220], 'accessPlease': [182], 'review': [183], 'our': [184], 'Terms': [185, 208], 'Conditions': [187, 210], 'Use': [189], 'check': [191], 'box': [192], 'below': [193, 216], 'share': [195, 218], 'version': [197, 221], 'article.I': [199], 'have': [200], 'read': [201], 'accept': [203], 'Wiley': [205], 'Online': [206], 'Library': [207], 'UseShareable': [212], 'LinkUse': [213], 'link': [215], 'a': [219, 234, 250, 493], 'article': [224], 'with': [225, 243, 247, 433], 'your': [226], 'friends': [227], 'colleagues.': [229], 'Learn': [230], 'more.Copy': [231], 'URL': [232], 'Share': [233], 'linkShare': [235], 'onEmailFacebookTwitterLinkedInRedditWechat': [236], 'References': [237], '1': [238], 'Diepgen': [239], 'TL.': [240], 'Longterm': [241], 'treatment': [242, 283], 'cetirizine': [244, 280], 'infants': [246], 'atopic': [248, 285, 434], 'dermatitis:': [249], 'multi-country,': [251], 'double-blind,': [252], 'randomized,': [253], 'placebo-controlled': [254], 'trial': [255], '(the': [256], 'ETAC': [257], 'trial)': [258], 'over': [259], '18': [260], 'months.': [261], 'Pediatr': [262], 'Allergy': [263, 290, 321, 374, 474, 527], 'Immunol': [264, 376, 475, 529], '2002;': [265], '13:': [266], '278–286.': [267], '2': [268], 'Hannuksela': [269], 'M,': [270, 382, 412, 481, 483], 'Kalimo': [271], 'K,': [272, 274, 346, 350, 414, 444, 446], 'Lammintausta': [273], 'et': [275, 301, 351, 387, 415], 'al.': [276, 302, 352, 388, 416], 'Dose': [277], 'ranging': [278], 'study:': [279], 'in': [281, 287, 465, 470, 522], 'dermatitis': [286], 'adults.': [288], 'Ann': [289], '1993;': [291], '70:': [292], '127–133.': [293], 'Shimizu': [295], 'T,': [296, 384], 'Nishihira': [297], 'J,': [298], 'Watanabe': [299], 'H,': [300, 327, 410], 'Cetirizine,': [303], 'an': [304, 419], 'H1-receptor': [305, 520], 'antagonist,': [306], 'expression': [309, 354], 'macrophage': [311], 'migration': [312], 'inhibitory': [313], 'factor:': [314], 'its': [315, 398, 501], 'potential': [316], 'anti-inflammatory': [317], 'action.': [318], 'Clin': [319, 375, 505, 528], 'Exp': [320], '2004;': [322, 439, 476], '34:': [323], '103–109.': [324], '4': [325], 'K.': [329], 'Thymus-': [330], 'activation-regulated': [332, 358, 393, 457], 'chemokine': [333, 359, 363, 394, 458], '(TARC)/CCL17': [334, 395], 'skin': [336, 523], 'diseases.': [337], 'J': [338, 373, 402, 436, 504, 526], 'Dermatol': [339, 404, 437], 'Sci': [340, 438], '2006;': [341], '43:': [342], '75–84.': [343], '5': [344], 'Fukuda': [345], 'Fujitsu': [347], 'Y,': [348], 'Seki': [349], 'Differential': [353], 'thymus-': [356, 391, 455], '(CCL17)': [360], 'macrophage-derived': [362], '(CCL22)': [364], 'human': [366, 461], 'from': [368, 431, 460], 'cornea,': [369], 'skin,': [370], 'lung.': [372], '2003;': [377], '111:': [378], '520–526.': [379], '6': [380], 'Komine': [381], 'Kakinuma': [383], 'Kagami': [385], 'S,': [386], 'Mechanism': [389], 'modulation': [399], 'roxithromycin.': [401], 'Invest': [403], '2005;': [405], '125:': [406], '491–498.': [407], '7': [408], 'Furukawa': [409], 'Takahashi': [411], 'Effect': [417], 'antiallergic': [420], 'drug': [421], '(olopatadine': [422], 'hydrochloride)': [423], 'on': [424, 454], 'TARC/CCL17': [425], 'MDC/CCL22': [427], 'PBMCs': [430], 'patients': [432], 'dermatitis.': [435], '36:': [440], '165–172.': [441], 'Asano': [443], 'Kanai': [445], 'Suzaki': [447], 'H.': [448], 'Suppressive': [449], 'activity': [450], 'fexofenadine': [452], 'peripheral': [462], 'blood': [463], 'leukocytes': [464], 'response': [466], 'antigenic': [468], 'stimulation': [469], 'vitro.': [471], 'Int': [472], 'Arch': [473], '133:': [477], '267–275.': [478], '9': [479], 'Sasa': [480], 'Naito': [482], 'Kojima': [484], 'T.': [485], 'Pharmacokinetics': [486], 'single': [488], 'multiple': [490], 'doses': [491], 'new': [494], 'anti-allergic': [495], 'drug,': [496], 'cetirizine,': [497], 'examination': [499], 'safety.': [502], 'Jpn': [503], 'Pharmacol': [506], 'Ther': [507], '1995;': [508, 530], '26:': [509], '509–522.': [510], '10': [511], 'Simons': [512, 516], 'FE,': [513], 'Murray': [514], 'HE,': [515], 'KJ.': [517], 'Quantitation': [518], 'antagonists': [521], 'serum.': [525], '95:': [531], '759–764.': [532], 'Citing': [533], 'Literature': [534], 'Volume51,': [535], 'Issue8August': [536], '2012Pages': [537], 'ReferencesRelatedInformation': [539]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1925251699', 'counts_by_year': [{'year': 2018, 'cited_by_count': 1}, {'year': 2016, 'cited_by_count': 1}, {'year': 2015, 'cited_by_count': 1}], 'updated_date': '2024-12-14T08:45:07.410807', 'created_date': '2016-06-24'}